Literature DB >> 7932823

Leptomeningeal tissue: a barrier against brain tumor cell invasion.

P H Pedersen1, G J Rucklidge, S J Mørk, A J Terzis, O Engebraaten, M Lund-Johansen, E O Backlund, O D Laerum, R Bjerkvig.   

Abstract

BACKGROUND: Primary brain tumors are characterized by an extensive infiltrative growth into the surrounding brain tissue. This process is confined to the central nervous system, and tumor cell metastasis to other organs is rare. However, other tumors of non-neural origin may frequently metastasize to the central nervous system.
PURPOSE: The purpose of the present study was to examine the invasive behavior of different glioma cells into tissues of neural (brain aggregates) as well as non-neural origin (leptomeningeal tissue). Using the same target tissues, the invasive characteristics of two neural metastatic tumors (one malignant melanoma and one small-cell lung carcinoma) were also studied. This direct comparison of the invasive behavior between tumors of neural and non-neural origin provides valuable information regarding the mechanisms of glioma cell dissemination in the central nervous system.
METHODS: The in vitro invasive behavior of human tumors of the central nervous system into human leptomeningeal tissue as well as into normal rat brain tissue was studied. For this purpose, a co-culture system consisting of tumor biopsy specimens, human leptomeningeal cell aggregates, and brain cell aggregates was established. Three glioblastomas, one oligodendroglioma, one meningioma, one small-cell lung carcinoma, and one malignant melanoma were studied.
RESULTS: In co-cultures of gliomas and leptomeningeal cell aggregates, a well-defined border between the two tissues was observed. The brain cell aggregates, in contrast, were consistently invaded by the glioma cells. The brain metastases showed a different invasion pattern. The metastatic cells invaded and progressively destroyed leptomeningeal cell aggregates, whereas they did not invade the brain cell aggregates. Upon confrontation of the leptomeningeal tissue with the meningioma, a fusion of the two tissues was observed. Immunostaining of the leptomeningeal tissue showed a strong expression of the basement membrane components fibronectin, collagen type IV, and laminin with no expression of glial fibrillary acidic protein, neuron-specific enolase, or S-100 protein.
CONCLUSIONS: The present study indicates that there may be important biologic differences between the invasive behavior of gliomas and non-neuroepithelial tumors. Our co-culture experiments suggest that leptomeningeal cells and associated acellular components may constitute a barrier against glioma cell invasion. However, this barrier may not be functional for metastatic tumors to the brain. The presence of glioma cells within the leptomeninges should not necessarily be taken as evidence of aggressive growth or as an indicator of malignancy.

Entities:  

Mesh:

Year:  1994        PMID: 7932823     DOI: 10.1093/jnci/86.21.1593

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.

Authors:  H Bouterfa; A R Darlapp; E Klein; T Pietsch; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Glioblastoma multiforme causing calvarial destruction: an unusual manifestation revisited.

Authors:  Vinay Gheyi; Ferdinand K Hui; Egon M Doppenberg; William Todd; William C Broaddus
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  Freiburg neuropathology case conference: widespread mass lesions after resection of a glioblastoma multiforme.

Authors:  C A Taschner; S Brendecke; A Weyerbrock; K Egger; M Prinz
Journal:  Clin Neuroradiol       Date:  2012-11-07       Impact factor: 3.649

Review 4.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 5.  Brain metastases as preventive and therapeutic targets.

Authors:  Patricia S Steeg; Kevin A Camphausen; Quentin R Smith
Journal:  Nat Rev Cancer       Date:  2011-04-07       Impact factor: 60.716

6.  Spatial expression of VEGF-A in human glioma.

Authors:  Mikael Johansson; Thomas Brännström; A Tommy Bergenheim; Roger Henriksson
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

Review 7.  Cellular and molecular mechanisms of metastasis as applied to carcinomatous meningitis.

Authors:  M Mareel; A Leroy; M Bracke
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 8.  Neoplastic meningitis: a unique disease process or a 'test tube' for evaluating cancer treatments?

Authors:  Mark R Gilbert
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 9.  The pathogenesis of neoplastic meningitis.

Authors:  Morris D Groves
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

10.  Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: An analysis of 59 cases.

Authors:  Fares Nigim; Jonathan F Critchlow; Ekkehard M Kasper
Journal:  Mol Clin Oncol       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.